Acute Graft-versus-Host Disease Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Acute Graft-versus-Host Disease Market is segmented By Drug Class (Corticosteroids, Immunosuppressive Agents, Kinase Inhibitors, Mesenchymal Stem Cells, Monoclonal Antibody), By Distribution Channel (Hospital, Pharmacies, Online Pharmacies, Retail Pharmacies), By Route of Administration (Oral, Topical, Intravenous), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned.

Acute Graft-versus-Host Disease Market Leaders

  • MaaT Pharma
  • Humanigen
  • Ironwood Pharmaceuticals
  • Incyte Corporation
  • Mesoblast
*Disclaimer: Major players are listed in no particular order.

Acute Graft-versus-Host Disease Market - Company List

  • MaaT Pharma
  • Humanigen
  • Ironwood Pharmaceuticals
  • Incyte Corporation
  • Mesoblast
  • Merck & Co. Inc
  • medac GmbH
  • CSL Limited
  • Equillium Inc
  • Cynata Therapeutics Limited
  • Novartis AG
  • Bristol-Myers Squibb